Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces the Change of the Chairman and General Manager
November 05, 2020 at 03:43 pm IST
Share
Chunghwa Chemical Synthesis & Biotech Co., Ltd. announced the Name and resume of the previous position holder: chairperson: Chunghwa Chemical Synthesis & Biotech Co.,Ltd Representative: Wang, Hsun-Sheng/CCPC of chairperson general manager: Wang, Hsun-Sheng/CCPC of chairperson. Name and resume of the new position holder: chairperson:Chunghwa Chemical Synthesis & Biotech Co.,Ltd Representative: Wang Hsieh Yi-Chen/Ma Jia De Enterprise Co., Ltd. of chairperson general manager:Wu, Chih-Yung/CCPC of Research and Develop Vice President. These changes are effective from November 05, 2020.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. 
